Paper33800554
The Role of CXCL16 in the Pathogenesis of Cancer and Other Diseases.
Korbecki J and 6 others. Int J Mol Sci, 2021. Cited by 142 papers, by iCite.
Cite this record
ConductScience Library. The Role of CXCL16 in the Pathogenesis of Cancer and Other Diseases. Papers, record 33800554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33800554
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chemokine CXCL16 | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Neoplasms | Major topic |
| Tumor Microenvironment | Major topic |
| ADAM10 Protein | |
| Amyloid Precursor Protein Secretases | |
| Animals | |
| Cell Movement | |
| Cell Proliferation | |
| Chemokines | |
| Endothelial Cells | |
| Humans | |
| Inflammation | |
| Lymphocytes, Tumor-Infiltrating | |
| Membrane Proteins | |
| Mesenchymal Stem Cells | |
| Mice | |
| Neoplasm Invasiveness | |
| Neoplasm Metastasis | |
| Receptors, CXCR6 |
Source PubMed
References192
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31753588 | CXCL16/CXCR6 axis promotes bleomycin-induced fibrotic process in MRC-5 cells via the PI3K/AKT/FOXO3a pathway. | Int Immunopharmacol | 2020 | https://conductscience.org/library/papers/31753588 | PubMed |
| 2 | 18293410 | Overexpression of CXCL16 and its receptor CXCR6/Bonzo promotes growth of human schwannomas. | Glia | 2008 | https://conductscience.org/library/papers/18293410 | PubMed |
| 3 | 11060282 | Molecular cloning of a novel scavenger receptor for oxidized low density lipoprotein, SR-PSOX, on macrophages. | J Biol Chem | 2000 | https://conductscience.org/library/papers/11060282 | PubMed |
| 4 | 28649646 | Human brain metastatic stroma attracts breast cancer cells via chemokines CXCL16 and CXCL12. | NPJ Breast Cancer | 2017 | https://conductscience.org/library/papers/28649646 | PubMed |
| 5 | 21744247 | Matrix metalloproteinases in tumorigenesis: an evolving paradigm. | Cell Mol Life Sci | 2011 | https://conductscience.org/library/papers/21744247 | PubMed |
| 6 | 31350295 | The Tumor Microenvironment Innately Modulates Cancer Progression. | Cancer Res | 2019 | https://conductscience.org/library/papers/31350295 | PubMed |
| 7 | 18452560 | CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells. | Cancer Sci | 2008 | https://conductscience.org/library/papers/18452560 | PubMed |
| 8 | 29353287 | High CXC Chemokine Ligand 16 (CXCL16) Expression Promotes Proliferation and Metastasis of Lung Cancer via Regulating the NF-κB Pathway. | Med Sci Monit | 2018 | https://conductscience.org/library/papers/29353287 | PubMed |
| 9 | 27725631 | Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers. | Nat Commun | 2016 | https://conductscience.org/library/papers/27725631 | PubMed |
| 10 | 28918166 | High expression of CXC chemokine receptor 6 associates with poor prognosis in patients with clear cell renal cell carcinoma. | Urol Oncol | 2017 | https://conductscience.org/library/papers/28918166 | PubMed |
| 11 | 29798856 | Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. | Science | 2018 | https://conductscience.org/library/papers/29798856 | PubMed |
| 12 | 25921630 | Blockade of CXCR6 reduces invasive potential of gastric cancer cells through inhibition of AKT signaling. | Int J Immunopathol Pharmacol | 2015 | https://conductscience.org/library/papers/25921630 | PubMed |
| 13 | 21527066 | Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma. | Chin J Cancer | 2011 | https://conductscience.org/library/papers/21527066 | PubMed |
| 14 | 26272362 | The prognostic significance of CXCL16 and its receptor C-X-C chemokine receptor 6 in prostate cancer. | Am J Pathol | 2015 | https://conductscience.org/library/papers/26272362 | PubMed |
| 15 | 30514792 | An Antibody Designed to Improve Adoptive NK-Cell Therapy Inhibits Pancreatic Cancer Progression in a Murine Model. | Cancer Immunol Res | 2019 | https://conductscience.org/library/papers/30514792 | PubMed |
| 16 | 17786442 | CXCR5 may be involved in the attraction of human metastatic neuroblastoma cells to the bone marrow. | Cancer Immunol Immunother | 2008 | https://conductscience.org/library/papers/17786442 | PubMed |
| 17 | 25359998 | The chemotaxis of M1 and M2 macrophages is regulated by different chemokines. | J Leukoc Biol | 2015 | https://conductscience.org/library/papers/25359998 | PubMed |
| 18 | 31652598 | Hepatitis C Virus Improves Human Tregs Suppressive Function and Promotes Their Recruitment to the Liver. | Cells | 2019 | https://conductscience.org/library/papers/31652598 | PubMed |
| 19 | 21203549 | CXCR6, a newly defined biomarker of tissue-specific stem cell asymmetric self-renewal, identifies more aggressive human melanoma cancer stem cells. | PLoS One | 2010 | https://conductscience.org/library/papers/21203549 | PubMed |
| 20 | 24864132 | Chemokine CXCL16 expression suppresses migration and invasiveness and induces apoptosis in breast cancer cells. | Mediators Inflamm | 2014 | https://conductscience.org/library/papers/24864132 | PubMed |
Cited by117
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 142 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42620371 | A dual pronged approach to cancer immune exclusion: tumor-derived LAIR-1 simultaneously drives fibrosis and blocks immune recruitment in glioma. | Res Sq | 2026 | https://conductscience.org/library/papers/42620371 | PubMed |
| 42598402 | Harnessing the abscopal effect: mechanistic insights and therapeutic strategies for systemic cancer immunotherapy. | Front Immunol | 2026 | https://conductscience.org/library/papers/42598402 | PubMed |
| 42548611 | Advancements in understanding and treating CXCL16/CXCR6 in tumors and in inflammatory diseases: a narrative review. | Front Immunol | 2026 | https://conductscience.org/library/papers/42548611 | PubMed |
| 42231969 | Deciphering the single-cell molecular landscape of ampullary cancer: A rare gastrointestinal malignancy. | iScience | 2026 | https://conductscience.org/library/papers/42231969 | PubMed |
| 42215564 | Downregulation of CXCL16/ADAM10 axis by Simvastatin attenuates tacrolimus-induced tubulointerstitial fibrosis. | Sci Rep | 2026 | https://conductscience.org/library/papers/42215564 | PubMed |
| 42211233 | Saikosaponin A Alleviates Hepatocellular Carcinoma Growth Induced by Chronic Stress via Regulating Tumor Immune Microenvironment. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42211233 | PubMed |
| 42120180 | CXCL16-driven CD4+ T cells orchestrate immunosurveillance against MHC-I-deficient hepatocellular tumors. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42120180 | PubMed |
| 42077068 | CXCL11 secreted by cancer-associated fibroblasts promotes nasopharyngeal carcinoma progression via CXCR3/PD-L1 axis. | Cell Adh Migr | 2026 | https://conductscience.org/library/papers/42077068 | PubMed |
| 42045172 | Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42045172 | PubMed |
| 42024199 | PFKP is required for chemoresistant phenotype of breast cancer through modulating the formation of CD133+ cancer stem like cells. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42024199 | PubMed |
| 42012021 | GlycA as an Effect Modifier of Protein-Mortality Associations: A Prospective Cohort Study. | Clin Transl Sci | 2026 | https://conductscience.org/library/papers/42012021 | PubMed |
| 41888164 | Smad7-based biologic targeting epidermis and stroma promotes healing of diabetic wounds in mice and pigs. | Nat Commun | 2026 | https://conductscience.org/library/papers/41888164 | PubMed |
| 41844740 | CHD1L promotes testicular cancer progression through epigenetic activation of the CXCR6/PI3K/AKT pathway. | Sci Rep | 2026 | https://conductscience.org/library/papers/41844740 | PubMed |
| 41762289 | KANK4 Regulates CXCL16 Glycosylation Through TMEM260 to Modulate Microglial Activation in Sepsis-associated Encephalopathy. | Inflammation | 2026 | https://conductscience.org/library/papers/41762289 | PubMed |
| 41721886 | Identification of Biomarkers Associated With Copper Metabolism in Ischemic Stroke Through Bulk RNA Sequencing and Mendelian Randomization Analysis. | Cell Mol Neurobiol | 2026 | https://conductscience.org/library/papers/41721886 | PubMed |
| 41700134 | Multiomics analysis of polyamine metabolism in colorectal cancer, highlighting the key role of extracellular putrescine in impairing CXCR6+CD8+ T cell anti-tumor activity. | PeerJ | 2026 | https://conductscience.org/library/papers/41700134 | PubMed |
| 41695367 | Identification of a neoplastic Tfh-like cellular subset in a mouse model of angioimmunoblastic T cell lymphoma. | Front Oncol | 2026 | https://conductscience.org/library/papers/41695367 | PubMed |
| 41641539 | Atherosclerotic Fibrous Plaques in Women Present ECM Remodeling Linked to TGF-β. | Circ Res | 2026 | https://conductscience.org/library/papers/41641539 | PubMed |
| 41604123 | CCL25/CCR9-induced M2 macrophage polarization promotes lung cancer progression via TGF-β1-mediated activation of the JAK/STAT-PIM2 signaling pathway. | Mol Cell Biochem | 2026 | https://conductscience.org/library/papers/41604123 | PubMed |
| 41547851 | APX3330 reverses the immunosuppressive tumor microenvironment during colorectal carcinogenesis. | Cancer Cell Int | 2026 | https://conductscience.org/library/papers/41547851 | PubMed |
Genes62
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33800554
GET https://conductscience.org/api/papers/v1/33800554/references?page=2